Shinnihonseiyaku Co., Ltd.
Shinnihonseiyaku Co., Ltd. (4931.T) Stock Competitors & Peer Comparison
See (4931.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4931.T | ¥2,433.00 | +4.74% | 51.4B | 22.43 | ¥108.48 | +1.44% |
| 3088.T | ¥3,311.00 | +2.83% | 1.3T | 24.72 | ¥133.95 | +1.33% |
| 3349.T | ¥9,729.00 | +2.05% | 771.1B | 24.89 | ¥390.89 | +0.72% |
| 7649.T | ¥3,824.00 | +1.03% | 692B | 16.95 | ¥225.59 | +0.92% |
| 3391.T | ¥11,300.00 | +0.71% | 550.4B | 33.57 | ¥336.60 | +2.36% |
| 9989.T | ¥4,644.00 | +1.29% | 543.2B | 17.68 | ¥262.72 | +2.80% |
| 3141.T | ¥2,586.50 | +0.64% | 537.4B | 29.43 | ¥87.89 | +1.39% |
| 3549.T | ¥4,167.00 | +2.48% | 421.3B | 23.91 | ¥174.28 | +0.34% |
| 3148.T | ¥3,545.00 | +1.87% | 229B | 14.59 | ¥242.90 | +1.92% |
| 9627.T | ¥6,099.00 | +1.06% | 213.9B | 23.07 | ¥264.33 | +1.31% |
Stock Comparison
4931.T vs 3088.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3088.T has a market cap of 1.3T. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3088.T trades at ¥3,311.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3088.T's P/E ratio is 24.72. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3088.T's ROE of +0.11%. Regarding short-term risk, 4931.T is less volatile compared to 3088.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4931.T.Check 3088.T's competition here
4931.T vs 3349.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3349.T has a market cap of 771.1B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3349.T trades at ¥9,729.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3349.T's P/E ratio is 24.89. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3349.T's ROE of +0.12%. Regarding short-term risk, 4931.T is more volatile compared to 3349.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3349.T's competition here
4931.T vs 7649.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 7649.T has a market cap of 692B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 7649.T trades at ¥3,824.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 7649.T's P/E ratio is 16.95. In terms of profitability, 4931.T's ROE is +0.11%, compared to 7649.T's ROE of +0.11%. Regarding short-term risk, 4931.T is more volatile compared to 7649.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 7649.T's competition here
4931.T vs 3391.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3391.T has a market cap of 550.4B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3391.T trades at ¥11,300.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3391.T's P/E ratio is 33.57. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3391.T's ROE of +0.06%. Regarding short-term risk, 4931.T is more volatile compared to 3391.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3391.T's competition here
4931.T vs 9989.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 9989.T has a market cap of 543.2B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 9989.T trades at ¥4,644.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 9989.T's P/E ratio is 17.68. In terms of profitability, 4931.T's ROE is +0.11%, compared to 9989.T's ROE of +0.12%. Regarding short-term risk, 4931.T is more volatile compared to 9989.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 9989.T's competition here
4931.T vs 3141.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3141.T has a market cap of 537.4B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3141.T trades at ¥2,586.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3141.T's P/E ratio is 29.43. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3141.T's ROE of +0.06%. Regarding short-term risk, 4931.T is more volatile compared to 3141.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3141.T's competition here
4931.T vs 3549.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3549.T has a market cap of 421.3B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3549.T trades at ¥4,167.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3549.T's P/E ratio is 23.91. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3549.T's ROE of +0.13%. Regarding short-term risk, 4931.T is more volatile compared to 3549.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3549.T's competition here
4931.T vs 3148.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3148.T has a market cap of 229B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3148.T trades at ¥3,545.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3148.T's P/E ratio is 14.59. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3148.T's ROE of +0.11%. Regarding short-term risk, 4931.T is more volatile compared to 3148.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3148.T's competition here
4931.T vs 9627.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 9627.T has a market cap of 213.9B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 9627.T trades at ¥6,099.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 9627.T's P/E ratio is 23.07. In terms of profitability, 4931.T's ROE is +0.11%, compared to 9627.T's ROE of +0.07%. Regarding short-term risk, 4931.T is less volatile compared to 9627.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4931.T.Check 9627.T's competition here
4931.T vs 9267.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 9267.T has a market cap of 144.8B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 9267.T trades at ¥4,765.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 9267.T's P/E ratio is 20.53. In terms of profitability, 4931.T's ROE is +0.11%, compared to 9267.T's ROE of +0.14%. Regarding short-term risk, 4931.T is less volatile compared to 9267.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4931.T.Check 9267.T's competition here
4931.T vs 3341.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3341.T has a market cap of 117B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3341.T trades at ¥3,915.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3341.T's P/E ratio is 84.03. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3341.T's ROE of +0.02%. Regarding short-term risk, 4931.T is more volatile compared to 3341.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3341.T's competition here
4931.T vs 3034.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3034.T has a market cap of 81.1B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3034.T trades at ¥2,160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3034.T's P/E ratio is 15.66. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3034.T's ROE of +0.09%. Regarding short-term risk, 4931.T is more volatile compared to 3034.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3034.T's competition here
4931.T vs 219A.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 219A.T has a market cap of 80.8B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 219A.T trades at ¥3,550.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 219A.T's P/E ratio is 88.33. In terms of profitability, 4931.T's ROE is +0.11%, compared to 219A.T's ROE of -0.10%. Regarding short-term risk, 4931.T is more volatile compared to 219A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 219A.T's competition here
4931.T vs 2664.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 2664.T has a market cap of 62.8B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 2664.T trades at ¥2,812.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 2664.T's P/E ratio is 12.87. In terms of profitability, 4931.T's ROE is +0.11%, compared to 2664.T's ROE of +0.04%. Regarding short-term risk, 4931.T is more volatile compared to 2664.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 2664.T's competition here
4931.T vs 7679.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 7679.T has a market cap of 45.6B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 7679.T trades at ¥2,327.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 7679.T's P/E ratio is 10.66. In terms of profitability, 4931.T's ROE is +0.11%, compared to 7679.T's ROE of +0.12%. Regarding short-term risk, 4931.T is more volatile compared to 7679.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 7679.T's competition here
4931.T vs 8095.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 8095.T has a market cap of 20.4B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 8095.T trades at ¥506.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 8095.T's P/E ratio is -10.33. In terms of profitability, 4931.T's ROE is +0.11%, compared to 8095.T's ROE of -0.08%. Regarding short-term risk, 4931.T is more volatile compared to 8095.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 8095.T's competition here
4931.T vs 3417.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3417.T has a market cap of 16.9B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3417.T trades at ¥1,238.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3417.T's P/E ratio is 6.40. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3417.T's ROE of +0.09%. Regarding short-term risk, 4931.T is less volatile compared to 3417.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4931.T.Check 3417.T's competition here
4931.T vs 4350.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 4350.T has a market cap of 14.6B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 4350.T trades at ¥501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 4350.T's P/E ratio is 11.60. In terms of profitability, 4931.T's ROE is +0.11%, compared to 4350.T's ROE of +0.08%. Regarding short-term risk, 4931.T is more volatile compared to 4350.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 4350.T's competition here
4931.T vs 3544.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 3544.T has a market cap of 11.5B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 3544.T trades at ¥838.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 3544.T's P/E ratio is 18.95. In terms of profitability, 4931.T's ROE is +0.11%, compared to 3544.T's ROE of +0.07%. Regarding short-term risk, 4931.T is more volatile compared to 3544.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 3544.T's competition here
4931.T vs 4890.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 4890.T has a market cap of 9.6B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 4890.T trades at ¥375.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 4890.T's P/E ratio is 47.41. In terms of profitability, 4931.T's ROE is +0.11%, compared to 4890.T's ROE of +0.15%. Regarding short-term risk, 4931.T is more volatile compared to 4890.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 4890.T's competition here
4931.T vs 2796.T Comparison August 2025
4931.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4931.T stands at 51.4B. In comparison, 2796.T has a market cap of 5.7B. Regarding current trading prices, 4931.T is priced at ¥2,433.00, while 2796.T trades at ¥501.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4931.T currently has a P/E ratio of 22.43, whereas 2796.T's P/E ratio is -6.98. In terms of profitability, 4931.T's ROE is +0.11%, compared to 2796.T's ROE of -0.11%. Regarding short-term risk, 4931.T is more volatile compared to 2796.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4931.T.Check 2796.T's competition here